Resultados de la búsqueda 871-880 of 3005 for SC

  1. Neurología - Ensayos clínicos

    This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns ...

  2. Oncología (médica) - Ensayos clínicos

    Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...

  3. Anemia de células falciformes - Diagnosis & treatment - Mayo Clinic

    Infórmate sobre los síntomas, las causas y el tratamiento de este trastorno sanguíneo hereditario que, en los Estados Unidos, es más común entre las ...

  4. Oncología (médica) - Ensayos clínicos

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  5. Medicina Física y Rehabilitación - Ensayos clínicos

    The purpose of this study is to determine the rate at which patients who underwent Spinal Cord Stimulation (SCS) trial ultimately progressed to SCS ...

  6. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to determine the effectiveness and safety of JCAR017 in adult subjects with relapsed or refractory Chronic Lymphocytic Leukemia ...

  7. Ensayos clínicos - Neurocirugía

    Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the ...

  8. Neurología - Ensayos clínicos

    This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns ...

  9. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to examine how well ascorbic acid and combination chemotherapy work in treating patients with lymphoma that has come back or does ...

  10. Oncología (médica) - Ensayos clínicos

    The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or Refractory Non-Hodgkin Lymphoma, (RR ...